EN | UA
EN | UA

Help Support

Back

EDS-FLU improves symptoms and sinus opacification in people with CRSsNP

CRSsNP CRSsNP
CRSsNP CRSsNP

What's new?

In CRSsNP patients, an exhalation delivery system with Fluticasone relieves both sinus opacification and symptoms.

Exhalation Delivery System with Fluticasone (EDS-FLU) substantially improved sinus opacification and symptoms of chronic rhinosinusitis without nasal polyps (CRSsNP) compared to EDS-placebo in a 24-week study. In order to manage CRSsNP, researchers sought to compare the impact of EDS-FLU versus EDS-placebo twice daily.

The average percentages of CT-opacified volume across ethmoid/maxillary sinuses (APOV; week 24) and combined symptom score (CSS; week 4) were the co-primary endpoints ascertained. Patient-reported Global Impression of Change (PGIC), Sleep (PSQI), and Quality-of-Life (SNOT-22, SF-36) were the other outcomes ascertained.

In this phase 3 randomized controlled study, the baseline values of mean CSS= 6.0 and APOV= 62.0% indicated moderate-severe illness. Compared to EDS-placebo (n = 75), both EDS-FLU doses—186µg and 372µg—significantly decreased symptoms and sinus opacification: CSS least-square (LS) mean alteration and APOV LS mean alteration in EDS-placebo, EDS-FLU 186µg, and EDS-FLU 372µg is depicted in Table 1:

At Week 24, EDS-FLU (n = 145) versus EDS-placebo (n = 75) also substantially enhanced secondary outcomes such as PGIC (60% versus 25% much/very much improved), PSQI Global score (LS mean -1.54 versus -.33), SF-36v2 (LS Mean PCS 4.9 versus 1.8), and SNOT-22 (LS mean -17.5 versus -8.7). Depression, headache, epistaxis, and COVID-19 were the adverse events reported. Hence, the intranasal steroid in a device that supplies the drug to the regions above the inferior turbinate and behind the nasal valve is promising for CRSsNP management.

Source:

Annals of Allergy, Asthma & Immunology

Article:

RANDOMIZED, CONTROLLED TRIAL OF EXHALATION DELIVERY SYSTEM WITH FLUTICASONE FOR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS

Authors:

A. Peters

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: